Style Change (style + change)

Distribution by Scientific Domains


Selected Abstracts


Speaking and Hearing Clearly: Talker and Listener Factors in Speaking Style Changes

LINGUISTICS & LANGUAGE COMPASS (ELECTRONIC), Issue 1 2009
Rajka Smiljani
This article provides an overview of the research concerning the nature of the distinct, listener-oriented speaking style called ,clear speech' and its effect on intelligibility for various listener populations. We review major findings that identify talker, listener and signal characteristics that contribute to the characteristically high intelligibility of clear speech. Understanding the interplay of these factors sheds light on the interaction between higher level cognitive and lower-level sensory and perceptual factors that affect language processing. Clear speech research is, thus, relevant for both its theoretical insights and practical applications. Throughout the review, we highlight open questions and promising future directions. [source]


Metabolic side effects of antipsychotic medication

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, Issue 8 2007
A. Tschoner
Summary The use of second-generation antipsychotics (SGAs) is associated with metabolic side effects including weight gain, diabetes mellitus and an atherogenic lipid profile. These adverse effects are not only the risk factors for cardiovascular disease, insulin resistance and diabetes mellitus leading to increased morbidity and mortality but may also impair the patient's adherence to treatment. SGAs in particular are associated with significant weight gain with clozapine and olanzapine carrying the highest risk, whereas newer agents, such as risperidone and aripiprazole, are considered to be less prone to cause weight gain. Consequently, a consensus development conference convened issuing recommendations on patient monitoring when treated with SGAs. The metabolic effects of antipsychotic drugs should be of concern when planning a patient's treatment strategy. Baseline screening and regular follow-up monitoring whose intervals should depend on the individual predisposition are advised. Possible therapeutical strategies for the management of drug-induced obesity include therapeutic approaches, such as life style change and pharmaceutical intervention. Drugs with a weight reducing effect become more important because of the lack of compliance with behavioural intervention. Topiramate, histamine-antagonists, dopaminergic- and serotoninergic agents have shown positive results in the management of psychotropic medication induced weight gain. However, further trials are required to support a specific therapeutical approach as well as studies to investigate the underlying mechanisms for future drug development. [source]


Explanatory style change in supportive-expressive dynamic therapy

JOURNAL OF CLINICAL PSYCHOLOGY, Issue 3 2005
Jacques P. Barber
Change in explanatory style (measured by the Attributional Style Questionnaire [ASQ]) has often been considered specific to cognitive therapy (CT). We used data from 59 patients who had received supportive-expressive (SE) dynamic therapy after meeting DSM-III-R criteria for a depressive spectrum disorder and who had completed the ASQ at intake and termination of treatment. We found that depressive symptoms decreased significantly and that explanatory style became more optimistic over the course of treatment. Furthermore, change in ASQ correlated with change in depression. There was some evidence suggesting that ASQ at termination predicted level of depression at follow-up. © 2004 Wiley Periodicals, Inc. J Clin Psychol. [source]


Resolving Disease Management Problems in European-American and Latino Couples with Type 2 Diabetes: The Effects of Ethnicity and Patient Gender,

FAMILY PROCESS, Issue 4 2000
Lawrence Fisher Ph.D.
The management of type 2 diabetes requires major life style changes. How patients and family members resolve disagreements about disease management affects how well the disease is managed over time. Our goal was to identify differences in how couples resolved disagreements about diabetes management based on ethnicity and patient gender. We recruited 65 Latino and 110 European-American (EA) couples in which one spouse had type 2 diabetes. Couples participated in a 10-minute videotaped, revealed differences interaction task that was evaluated with 7 reliable observer ratings: warm-engagement, hostility, avoidance, amount of conflict resolution, off-task behavior, patient dominance, and dialogue. A series of 2 × 2, Ethnicity × Sex ANOVAs indicated significant effects for Ethnicity and for the Ethnicity × Sex interaction, but not for Sex. Latino couples were rated as significantly more emotionally close, less avoidant, less hostile toward each other, and had less dominant patients than EA couples; however, Latino couples achieved significantly less problem resolution and were more frequently off-task than EA couples. These findings were qualified by patient gender. The findings highlight important differences in how couples manage diabetes based on ethnicity and patient gender, and suggest that effective family-based programs of intervention must take both characteristics into account. [source]